ParkinsonCanadaV1, France, Analysis, bibRecord, 000075

Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling

Identifieur interne : 000075 ( France/Analysis ); précédent : 000074; suivant : 000076

Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling

Auteurs : L. Cobret [France] ; M L De Tauzia [France] ; J. Ferent [Canada] ; E. Traiffort [France] ; I. Hénaoui [France] ; F. Godin [France] ; E. Kellenberger [France] ; D. Rognan [France] ; J. Pantel [France] ; H. Bénédetti [France] ; S. Morisset-Lopez [France]

Source :

British Journal of Pharmacology [ 0007-1188 ] ; 2014.

RBID : PMC:4301693

Abstract

Background and Purpose

The transmembrane protein LINGO-1 is a negative regulator in the nervous system mainly affecting axonal regeneration, neuronal survival, oligodendrocyte differentiation and myelination. However, the molecular mechanisms regulating its functions are poorly understood. In the present study, we investigated the formation and the role of LINGO-1 cis-dimers in the regulation of its biological activity.

Experimental Approach

LINGO-1 homodimers were identified in both HEK293 and SH-SY5Y cells using co-immunoprecipitation experiments and BRET saturation analysis. We performed a hypothesis-driven screen for identification of small-molecule protein–protein interaction modulators of LINGO-1 using a BRET-based assay, adapted for screening. The compound identified was further assessed for effects on LINGO-1 downstream signalling pathways using Western blotting analysis and AlphaScreen technology.

Key Results

LINGO-1 was present as homodimers in primary neuronal cultures. LINGO-1 interacted homotypically in cis-orientation and LINGO-1 cis-dimers were formed early during LINGO-1 biosynthesis. A BRET-based assay allowed us to identify phenoxybenzamine as the first conformational modulator of LINGO-1 dimers. In HEK-293 cells, phenoxybenzamine was a positive modulator of LINGO-1 function, increasing the LINGO-1-mediated inhibition of EGF receptor signalling and Erk phosphorylation.

Conclusions and Implications

Our data suggest that LINGO-1 forms constitutive cis-dimers at the plasma membrane and that low MW compounds affecting the conformational state of these dimers can regulate LINGO-1 downstream signalling pathways. We propose that targeting the LINGO-1 dimerization interface opens a new pharmacological approach to the modulation of its function and provides a new strategy for drug discovery.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301693

DOI: 10.1111/bph.12945
PubMed: 25257685
PubMed Central: 4301693

Affiliations:

Canada, France

Links to Exploration step

PMC:4301693

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Targeting the <italic>cis</italic>
-dimerization of LINGO-1 with low MW compounds affects its downstream signalling</title>
<author><name sortKey="Cobret, L" sort="Cobret, L" uniqKey="Cobret L" first="L" last="Cobret">L. Cobret</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Tauzia, M L" sort="De Tauzia, M L" uniqKey="De Tauzia M" first="M L" last="De Tauzia">M L De Tauzia</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ferent, J" sort="Ferent, J" uniqKey="Ferent J" first="J" last="Ferent">J. Ferent</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Institut de Recherches Cliniques de Montréal</institution>
<addr-line>Montréal, Quebec, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Montréal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Traiffort, E" sort="Traiffort, E" uniqKey="Traiffort E" first="E" last="Traiffort">E. Traiffort</name>
<affiliation wicri:level="1"><nlm:aff id="au3"><institution>INSERM-Université Paris Sud U788</institution>
<addr-line>Le Kremlin-Bicêtre, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Le Kremlin-Bicêtre</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Henaoui, I" sort="Henaoui, I" uniqKey="Henaoui I" first="I" last="Hénaoui">I. Hénaoui</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="au4"><institution>Institut de Pharmacologie Moléculaire et Cellulaire</institution>
<addr-line>Valbonne, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Valbonne</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Godin, F" sort="Godin, F" uniqKey="Godin F" first="F" last="Godin">F. Godin</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kellenberger, E" sort="Kellenberger, E" uniqKey="Kellenberger E" first="E" last="Kellenberger">E. Kellenberger</name>
<affiliation wicri:level="1"><nlm:aff id="au5"><institution>Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg</institution>
<addr-line>Illkirch, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Illkirch</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="au6"><institution>MEDALIS Drug Discovery Center</institution>
<addr-line>Illkirch, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Illkirch</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rognan, D" sort="Rognan, D" uniqKey="Rognan D" first="D" last="Rognan">D. Rognan</name>
<affiliation wicri:level="1"><nlm:aff id="au5"><institution>Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg</institution>
<addr-line>Illkirch, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Illkirch</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="au6"><institution>MEDALIS Drug Discovery Center</institution>
<addr-line>Illkirch, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Illkirch</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pantel, J" sort="Pantel, J" uniqKey="Pantel J" first="J" last="Pantel">J. Pantel</name>
<affiliation wicri:level="1"><nlm:aff id="au7"><institution>Centre de Psychiatrie et Neurosciences, INSERM U894</institution>
<addr-line>Paris, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Benedetti, H" sort="Benedetti, H" uniqKey="Benedetti H" first="H" last="Bénédetti">H. Bénédetti</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Morisset Lopez, S" sort="Morisset Lopez, S" uniqKey="Morisset Lopez S" first="S" last="Morisset-Lopez">S. Morisset-Lopez</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">25257685</idno>
<idno type="pmc">4301693</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301693</idno>
<idno type="RBID">PMC:4301693</idno>
<idno type="doi">10.1111/bph.12945</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000523</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000523</idno>
<idno type="wicri:Area/Pmc/Curation">000523</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000523</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000404</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000404</idno>
<idno type="wicri:Area/Ncbi/Merge">001920</idno>
<idno type="wicri:Area/Ncbi/Curation">001920</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001920</idno>
<idno type="wicri:Area/Main/Merge">000915</idno>
<idno type="wicri:Area/Main/Curation">000913</idno>
<idno type="wicri:Area/Main/Exploration">000913</idno>
<idno type="wicri:Area/France/Extraction">000075</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Targeting the <italic>cis</italic>
-dimerization of LINGO-1 with low MW compounds affects its downstream signalling</title>
<author><name sortKey="Cobret, L" sort="Cobret, L" uniqKey="Cobret L" first="L" last="Cobret">L. Cobret</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Tauzia, M L" sort="De Tauzia, M L" uniqKey="De Tauzia M" first="M L" last="De Tauzia">M L De Tauzia</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ferent, J" sort="Ferent, J" uniqKey="Ferent J" first="J" last="Ferent">J. Ferent</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Institut de Recherches Cliniques de Montréal</institution>
<addr-line>Montréal, Quebec, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Montréal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Traiffort, E" sort="Traiffort, E" uniqKey="Traiffort E" first="E" last="Traiffort">E. Traiffort</name>
<affiliation wicri:level="1"><nlm:aff id="au3"><institution>INSERM-Université Paris Sud U788</institution>
<addr-line>Le Kremlin-Bicêtre, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Le Kremlin-Bicêtre</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Henaoui, I" sort="Henaoui, I" uniqKey="Henaoui I" first="I" last="Hénaoui">I. Hénaoui</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="au4"><institution>Institut de Pharmacologie Moléculaire et Cellulaire</institution>
<addr-line>Valbonne, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Valbonne</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Godin, F" sort="Godin, F" uniqKey="Godin F" first="F" last="Godin">F. Godin</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kellenberger, E" sort="Kellenberger, E" uniqKey="Kellenberger E" first="E" last="Kellenberger">E. Kellenberger</name>
<affiliation wicri:level="1"><nlm:aff id="au5"><institution>Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg</institution>
<addr-line>Illkirch, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Illkirch</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="au6"><institution>MEDALIS Drug Discovery Center</institution>
<addr-line>Illkirch, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Illkirch</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rognan, D" sort="Rognan, D" uniqKey="Rognan D" first="D" last="Rognan">D. Rognan</name>
<affiliation wicri:level="1"><nlm:aff id="au5"><institution>Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg</institution>
<addr-line>Illkirch, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Illkirch</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="au6"><institution>MEDALIS Drug Discovery Center</institution>
<addr-line>Illkirch, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Illkirch</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pantel, J" sort="Pantel, J" uniqKey="Pantel J" first="J" last="Pantel">J. Pantel</name>
<affiliation wicri:level="1"><nlm:aff id="au7"><institution>Centre de Psychiatrie et Neurosciences, INSERM U894</institution>
<addr-line>Paris, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Benedetti, H" sort="Benedetti, H" uniqKey="Benedetti H" first="H" last="Bénédetti">H. Bénédetti</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Morisset Lopez, S" sort="Morisset Lopez, S" uniqKey="Morisset Lopez S" first="S" last="Morisset-Lopez">S. Morisset-Lopez</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Centre de Biophysique Moléculaire, Département biologie cellulaire et cibles thérapeutiques, CNRS, UPR 4301, University of Orléans and INSERM</institution>
<addr-line>Orléans, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Orléans</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">British Journal of Pharmacology</title>
<idno type="ISSN">0007-1188</idno>
<idno type="eISSN">1476-5381</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec><title>Background and Purpose</title>
<p>The transmembrane protein LINGO-1 is a negative regulator in the nervous system mainly affecting axonal regeneration, neuronal survival, oligodendrocyte differentiation and myelination. However, the molecular mechanisms regulating its functions are poorly understood. In the present study, we investigated the formation and the role of LINGO-1 <italic>cis</italic>
-dimers in the regulation of its biological activity.</p>
</sec>
<sec><title>Experimental Approach</title>
<p>LINGO-1 homodimers were identified in both HEK293 and SH-SY5Y cells using co-immunoprecipitation experiments and BRET saturation analysis. We performed a hypothesis-driven screen for identification of small-molecule protein–protein interaction modulators of LINGO-1 using a BRET-based assay, adapted for screening. The compound identified was further assessed for effects on LINGO-1 downstream signalling pathways using Western blotting analysis and AlphaScreen technology.</p>
</sec>
<sec><title>Key Results</title>
<p>LINGO-1 was present as homodimers in primary neuronal cultures. LINGO-1 interacted homotypically in <italic>cis</italic>
-orientation and LINGO-1 <italic>cis-</italic>
dimers were formed early during LINGO-1 biosynthesis. A BRET-based assay allowed us to identify phenoxybenzamine as the first conformational modulator of LINGO-1 dimers. In HEK-293 cells, phenoxybenzamine was a positive modulator of LINGO-1 function, increasing the LINGO-1-mediated inhibition of EGF receptor signalling and Erk phosphorylation.</p>
</sec>
<sec><title>Conclusions and Implications</title>
<p>Our data suggest that LINGO-1 forms constitutive <italic>cis</italic>
-dimers at the plasma membrane and that low MW compounds affecting the conformational state of these dimers can regulate LINGO-1 downstream signalling pathways. We propose that targeting the LINGO-1 dimerization interface opens a new pharmacological approach to the modulation of its function and provides a new strategy for drug discovery.</p>
</sec>
</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>France</li>
</country>
</list>
<tree><country name="France"><noRegion><name sortKey="Cobret, L" sort="Cobret, L" uniqKey="Cobret L" first="L" last="Cobret">L. Cobret</name>
</noRegion>
<name sortKey="Benedetti, H" sort="Benedetti, H" uniqKey="Benedetti H" first="H" last="Bénédetti">H. Bénédetti</name>
<name sortKey="De Tauzia, M L" sort="De Tauzia, M L" uniqKey="De Tauzia M" first="M L" last="De Tauzia">M L De Tauzia</name>
<name sortKey="Godin, F" sort="Godin, F" uniqKey="Godin F" first="F" last="Godin">F. Godin</name>
<name sortKey="Henaoui, I" sort="Henaoui, I" uniqKey="Henaoui I" first="I" last="Hénaoui">I. Hénaoui</name>
<name sortKey="Henaoui, I" sort="Henaoui, I" uniqKey="Henaoui I" first="I" last="Hénaoui">I. Hénaoui</name>
<name sortKey="Kellenberger, E" sort="Kellenberger, E" uniqKey="Kellenberger E" first="E" last="Kellenberger">E. Kellenberger</name>
<name sortKey="Kellenberger, E" sort="Kellenberger, E" uniqKey="Kellenberger E" first="E" last="Kellenberger">E. Kellenberger</name>
<name sortKey="Morisset Lopez, S" sort="Morisset Lopez, S" uniqKey="Morisset Lopez S" first="S" last="Morisset-Lopez">S. Morisset-Lopez</name>
<name sortKey="Pantel, J" sort="Pantel, J" uniqKey="Pantel J" first="J" last="Pantel">J. Pantel</name>
<name sortKey="Rognan, D" sort="Rognan, D" uniqKey="Rognan D" first="D" last="Rognan">D. Rognan</name>
<name sortKey="Rognan, D" sort="Rognan, D" uniqKey="Rognan D" first="D" last="Rognan">D. Rognan</name>
<name sortKey="Traiffort, E" sort="Traiffort, E" uniqKey="Traiffort E" first="E" last="Traiffort">E. Traiffort</name>
</country>
<country name="Canada"><noRegion><name sortKey="Ferent, J" sort="Ferent, J" uniqKey="Ferent J" first="J" last="Ferent">J. Ferent</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000075 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000075 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     PMC:4301693
   |texte=   Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:25257685" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling

Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.